Related Experiment Video
Updated: Mar 14, 2026

08:00
Dissection and Isolation of Murine Glia from Multiple Central Nervous System Regions
Published on: June 4, 2020
4.0K
Interferon-γ blocks signalling through PDGFRβ in human brain pericytes.
Deidre Jansson1,2,3, Emma L Scotter1,3, Justin Rustenhoven1,3
1Department of Pharmacology and Clinical Pharmacology, The University of Auckland, 1023, Auckland, New Zealand.
Journal of Neuroinflammation
|September 23, 2016
Summary
Chronic brain inflammation disrupts the blood-brain barrier (BBB) by altering brain pericyte function. Interferon-gamma (IFNγ) impairs platelet-derived growth factor receptor-beta (PDGFRβ) signaling, leading to BBB dysfunction in neurological disorders.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Neuroinflammation and blood-brain barrier (BBB) disruption are hallmarks of various brain disorders.
- The precise mechanisms linking inflammation to BBB breakdown remain unclear.
- Brain pericytes are crucial for BBB integrity and possess immune activity.
Purpose of the Study:
- To investigate how inflammation affects brain pericyte biology.
- To test the hypothesis that inflammation regulates the BBB by altering pericyte function.
Main Methods:
- Primary adult human brain pericytes were exposed to chronic interferon-gamma (IFNγ) for 4 days.
- Assessed effects on platelet-derived growth factor receptor-beta (PDGFRβ) expression, signaling, pericyte proliferation, and migration.
- Utilized qRT-PCR, immunocytochemistry, flow cytometry, and western blotting.
Main Results:
- Chronic IFNγ enhanced PDGF-BB-induced PDGFRβ phosphorylation, internalization, and degradation.
- IFNγ treatment inhibited PDGF-BB-mediated pericyte proliferation and migration.
- These changes highlight a significant impact on pericyte functional biology.
Conclusions:
- PDGFRβ is essential for pericyte function and BBB integrity.
- Inflammation-induced alterations in PDGFRβ signaling offer a mechanism for BBB leakage.
- Findings link chronic brain inflammation to BBB dysfunction in neurological diseases.

